Scavenger receptors that recognize advanced glycation end products

被引:86
作者
Miyazaki, A
Nakayama, H
Horiuchi, S
机构
[1] Kumamoto Univ, Sch Med, Dept Biochem, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Dept Biofunct Chem, Fac Pharmaceut Sci, Kumamoto 8600811, Japan
关键词
D O I
10.1016/S1050-1738(02)00171-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Scavenger receptors recognize modified low-density lipoproteins (LDLs) such as acetylated LDL and oxidized LDL. Advanced glycation end products (AGE), which are generated through long-term exposure of proteins to glucose, also behave as active ligands for some scavenger receptors, including class A scavenger receptor (SR-A) and, class B scavenger receptors such as CD36 and scavenger receptor, class B, type I (SR-BI). SR-BI, the first identified high-density lipoprotein (HDL) receptor, plays key roles in reverse cholesterol transport by promoting selective uptake of cholesteryl esters (CE) in HDL by hepatocytes, and cholesterol efflux of unesterified cholesterol from peripheral cells to HDL. Using Chinese hamster ovary cells overexpressing SR-BI (CHO-SR-BI cells), it was demonstrated that AGE-bovine serum albumin binds to SR-BI and inhibits selective uptake of HDL-CE by CHO-SR-BI cells as well as cholesterol efflux from CHO-SR-BI cells to HPL, suggesting potential roles of AGE in diabetic dyslipidemia and accelerated atherosclerosis in diabetes. (C) 2002, Elsevier Science Inc.
引用
收藏
页码:258 / 262
页数:5
相关论文
共 37 条
  • [1] ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665
  • [2] Identification of scavenger receptor SR-BI as a high density lipoprotein receptor
    Acton, S
    Rigotti, A
    Landschulz, KT
    Xu, SZ
    Hobbs, HH
    Krieger, M
    [J]. SCIENCE, 1996, 271 (5248) : 518 - 520
  • [3] ACTON SL, 1994, J BIOL CHEM, V269, P21003
  • [4] MACROPHAGE SCAVENGER RECEPTOR MEDIATES THE ENDOCYTIC UPTAKE AND DEGRADATION OF ADVANCED GLYCATION END-PRODUCTS OF THE MAILLARD REACTION
    ARAKI, N
    HIGASHI, T
    MORI, T
    SHIBAYAMA, R
    KAWABE, Y
    KODAMA, T
    TAKAHASHI, K
    SHICHIRI, M
    HORIUCHI, S
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 230 (02): : 408 - 415
  • [5] Role of oxidative stress in diabetic complications - A new perspective on an old paradigm
    Baynes, JW
    Thorpe, SR
    [J]. DIABETES, 1999, 48 (01) : 1 - 9
  • [6] CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors
    Chinetti, G
    Gbaguidi, FG
    Griglio, S
    Mallat, Z
    Antonucci, M
    Poulain, P
    Chapman, J
    Fruchart, JC
    Tedgui, A
    Najib-Fruchart, J
    Staels, B
    [J]. CIRCULATION, 2000, 101 (20) : 2411 - 2417
  • [7] ENDEMANN G, 1993, J BIOL CHEM, V268, P11811
  • [8] Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
    Febbraio, M
    Podrez, EA
    Smith, JD
    Hajjar, DP
    Hazen, SL
    Hoff, HF
    Sharma, K
    Silverstein, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) : 1049 - 1056
  • [9] CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism
    Febbraio, M
    Hajjar, DP
    Silverstein, RL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (06) : 785 - 791
  • [10] Advanced glycation end products (AGE)-modified proteins and their potential relevance to atherosclerosis
    Horiuchi, S
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1996, 6 (05) : 163 - 168